本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

GT Biopharma Inc.

2.58
+0.23009.79%
成交量:1.66万
成交额:4.18万
市值:654.39万
市盈率:-0.37
高:2.70
开:2.34
低:2.34
收:2.35
数据加载中...
2025/04/14

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/04

重要事件披露

Form 8-K - Current report
2025/03/12

SEC问询函

Form CORRESP - Correspondence
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/27

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/27

重要事件披露

Form 8-K - Current report
2024/12/23

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/28

重要事件披露

Form 8-K - Current report
2024/11/21

重要事件披露

Form 8-K - Current report
2024/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/16

重要事件披露

Form 8-K - Current report
2024/08/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/27

SEC问询函

Form CORRESP - Correspondence
2024/06/27

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/20

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/07

重要事件披露

Form 8-K - Current report